Susquehanna International Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.12M | Sell |
5,914
-893
| -13% | -$156K | ﹤0.01% | 7587 |
|
|
2025
Q4 | $1.16M | Sell |
6,807
-51,537
| -88% | -$7.9M | ﹤0.01% | 6858 |
|
|
2025
Q3 | $7.69M | Buy |
58,344
+18,254
| +46% | +$2.19M | ﹤0.01% | 3398 |
|
|
2025
Q2 | $4.25M | Buy |
40,090
+15,898
| +66% | +$1.73M | ﹤0.01% | 4279 |
|
|
2025
Q1 | $3M | Buy |
24,192
+12,518
| +107% | +$1.63M | ﹤0.01% | 4648 |
|
|
2024
Q4 | $1.44M | Sell |
11,674
-16,558
| -59% | -$1.95M | ﹤0.01% | 6049 |
|
|
2024
Q3 | $3.15M | Sell |
28,232
-80,876
| -74% | -$8.86M | ﹤0.01% | 4454 |
|
|
2024
Q2 | $11.6M | Buy |
109,108
+66,294
| +155% | +$7.29M | ﹤0.01% | 2292 |
|
|
2024
Q1 | $5.16M | Sell |
42,814
-30,049
| -41% | -$3.68M | ﹤0.01% | 3591 |
|
|
2023
Q4 | $8.96M | Buy |
72,863
+57,167
| +364% | +$7.13M | ﹤0.01% | 2775 |
|
|
2023
Q3 | $2.03M | Buy |
15,696
+10,425
| +198% | +$1.39M | ﹤0.01% | 5101 |
|
|
2023
Q2 | $653K | Sell |
5,271
-61,820
| -92% | -$8.32M | ﹤0.01% | 7688 |
|
|
2023
Q1 | $9.82M | Buy |
67,091
+59,943
| +839% | +$8.87M | ﹤0.01% | 2475 |
|
|
2022
Q4 | $1.14M | Buy |
7,148
+1,916
| +37% | +$281K | ﹤0.01% | 5887 |
|
|
2022
Q3 | $697K | Buy |
5,232
+459
| +10% | +$69.8K | ﹤0.01% | 7579 |
|
|
2022
Q2 | $745K | Buy |
4,773
+1,925
| +68% | +$296K | ﹤0.01% | 7249 |
|
|
2022
Q1 | $443K | Sell |
2,848
-22,298
| -89% | -$3.24M | ﹤0.01% | 9282 |
|
|
2021
Q4 | $3.2M | Sell |
25,146
-28,670
| -53% | -$3.77M | ﹤0.01% | 4526 |
|
|
2021
Q3 | $7.01M | Sell |
53,816
-39,236
| -42% | -$5.93M | ﹤0.01% | 3400 |
|
|
2021
Q2 | $16.5M | Buy |
93,052
+63,568
| +216% | +$11M | ﹤0.01% | 2274 |
|
|
2021
Q1 | $4.85M | Sell |
29,484
-53,106
| -64% | -$8.74M | ﹤0.01% | 3965 |
|
|
2020
Q4 | $13.6M | Buy |
82,590
+1,021
| +1% | +$152K | ﹤0.01% | 2136 |
|
|
2020
Q3 | $11.6M | Buy |
81,569
+28,346
| +53% | +$3.51M | ﹤0.01% | 2010 |
|
|
2020
Q2 | $5.87M | Buy |
53,223
+43,267
| +435% | +$4.78M | ﹤0.01% | 2782 |
|
|
2020
Q1 | $993K | Buy |
9,956
+4,813
| +94% | +$622K | ﹤0.01% | 5423 |
|
|
2019
Q4 | $768K | Sell |
5,143
-6,009
| -54% | -$818K | ﹤0.01% | 6045 |
|
|
2019
Q3 | $1.43M | Sell |
11,152
-15,508
| -58% | -$2.08M | ﹤0.01% | 4928 |
|
|
2019
Q2 | $3.8M | Buy |
+26,660
| New | +$3.58M | ﹤0.01% | 3102 |
|
|
2019
Q1 | – | Sell |
-43,232
| Closed | -$5.64M | – | 9338 |
|
|
2018
Q4 | $5.36M | Buy |
+43,232
| New | +$6.41M | ﹤0.01% | 2211 |
|
|
2018
Q1 | – | Sell |
-5,623
| Closed | -$825K | – | 9747 |
|
|
2017
Q4 | $757K | Buy |
5,623
+2,042
| +57% | +$283K | ﹤0.01% | 5798 |
|
|
2017
Q3 | $524K | Sell |
3,581
-8,300
| -70% | -$1.26M | ﹤0.01% | 6431 |
|
|
2017
Q2 | $1.85M | Buy |
+11,881
| New | +$1.82M | ﹤0.01% | 4047 |
|
|
2017
Q1 | – | Sell |
-41,811
| Closed | -$5.45M | – | 9441 |
|
|
2016
Q4 | $4.56M | Sell |
41,811
-59,108
| -59% | -$6.58M | ﹤0.01% | 2568 |
|
|
2016
Q3 | $12.3M | Buy |
100,919
+856
| +0.9% | +$115K | 0.01% | 1372 |
|
|
2016
Q2 | $14.1M | Buy |
100,063
+59,803
| +149% | +$8.82M | 0.01% | 1197 |
|
|
2016
Q1 | $5.26M | Sell |
40,260
-91,520
| -69% | -$11.4M | ﹤0.01% | 2241 |
|
|
2015
Q4 | $18.5M | Buy |
131,780
+35,241
| +37% | +$4.88M | 0.01% | 1202 |
|
|
2015
Q3 | $12.8M | Buy |
96,539
+62,781
| +186% | +$10.8M | 0.01% | 1595 |
|
|
2015
Q2 | $5.94M | Sell |
33,758
-17,868
| -35% | -$3.21M | ﹤0.01% | 2653 |
|
|
2015
Q1 | $8.92M | Sell |
51,626
-145
| -0.3% | -$24.9K | ﹤0.01% | 1994 |
|
|
2014
Q4 | $8.48M | Sell |
51,771
-6,527
| -11% | -$1.08M | ﹤0.01% | 2215 |
|
|
2014
Q3 | $9.36M | Sell |
58,298
-119,552
| -67% | -$18.4M | ﹤0.01% | 2183 |
|
|
2014
Q2 | $26.1M | Sell |
177,850
-43,958
| -20% | -$6.1M | 0.01% | 1163 |
|
|
2014
Q1 | $30.8M | Buy |
221,808
+156,055
| +237% | +$23.5M | 0.01% | 922 |
|
|
2013
Q4 | $8.32M | Sell |
65,753
-27,068
| -29% | -$2.8M | ﹤0.01% | 2273 |
|
|
2013
Q3 | $8.54M | Sell |
92,821
-37,194
| -29% | -$3M | ﹤0.01% | 2064 |
|
|
2013
Q2 | $8.94M | Buy |
+130,015
| New | +$7.95M | 0.01% | 1906 |
|
Other funds holding JAZZ
VPM
VCM
EC
Susquehanna International Group's JAZZ Position: Q1 2026 in Review
Susquehanna International Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q1 2026, selling an estimated $156K and leaving 5,914 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7587.
Susquehanna International Group first reported a position in JAZZ in Q2 2013 and has held it in 47 quarters since. The position peaked at $30.8M in Q1 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Susquehanna International Group held 5,914 shares of Jazz Pharmaceuticals worth $1.12M as of Q1 2026.
- Susquehanna International Group sold 893 Jazz Pharmaceuticals shares in Q1 2026, an estimated $156K.
- Jazz Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7587 holding.
- Susquehanna International Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Jazz Pharmaceuticals position peaked at $30.8M in Q1 2014.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.